January |
| ||||||
| Principal company | Partner company | Value ($M) | Technologies | Date |
| Replace Therapeutics Inc. | Tome Biosciences Inc. | $185.00 | DNA sequencing technology | 1/2/2024 |
| Sanreno Therapeutics | Novartis AG | Payment unspecified | Small molecule therapeutic; biological therapeutic; film coating; immuno-oncology; immunoglobulin G isotype antibody; infusion; intravenous formulation; monoclonal antibody humanized; oral formulation; recombinant monoclonal antibody therapy; subcutaneous formulation; tablet formulation | 1/5/2024 |